Stay updated on Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page adds a Locations section showing three study sites (Duarte, CA; Aurora, CO; Philadelphia, PA) and their institutions, and displays a Revision: v3.3.3 tag.
    Difference
    0.4%
    Check dated 2025-12-23T17:36:51.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.2.0 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-24T21:10:27.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    A site-wide notice about government funding and NIH operating status was removed, not affecting the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T18:31:44.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the Study Details page. The content and structure appear consistent with prior versions.
    Difference
    0.4%
    Check dated 2025-11-03T13:43:29.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Update adds a government operating-status notice and increments version to v3.2.0; it removes the Mature T-cell and NK-cell non-Hodgkin lymphoma resource (v3.1.0).
    Difference
    3%
    Check dated 2025-10-06T01:46:43.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Page version metadata updated to v3.1.0; older version tag v3.0.2 removed; a chemical name (Methylprednisolone Acetate) was deleted from the content.
    Difference
    0.2%
    Check dated 2025-09-28T23:28:05.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial page.